<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101573691</journal-id>
<journal-id journal-id-type="pubmed-jr-id">39703</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Rep</journal-id>
<journal-title-group>
<journal-title>Cell reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2211-1247</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28009282</article-id>
<article-id pub-id-type="pmc">5240804</article-id>
<article-id pub-id-type="doi">10.1016/j.celrep.2016.11.067</article-id>
<article-id pub-id-type="manuscript">NIHMS836970</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Beyond Epilepsy and Autism: Disruption of <italic>GABRB3</italic> Causes Ocular Hypopigmentation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Delahanty</surname>
<given-names>Ryan J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yanfeng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bichell</surname>
<given-names>Terry Jo</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Wangzhen</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Verdier</surname>
<given-names>Kelienne</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Macdonald</surname>
<given-names>Robert L.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Lili</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boyd</surname>
<given-names>Kelli</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Janice</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Jing-Qiong</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="author-notes" rid="FN1">9</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A2"><label>2</label>Department of Human Genetics, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A3"><label>3</label>Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A4"><label>4</label>Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A5"><label>5</label>Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A6"><label>6</label>Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A7"><label>7</label>Pathology Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<aff id="A8"><label>8</label>Vanderbilt Electron Microscopy Core, Vanderbilt University Medical Center, Nashville, TN 37212</aff>
<author-notes>
<corresp id="cor1"><label>*</label><bold>Corresponding Author</bold>: Jing-Qiong Kang, M.D, Ph.D., Vanderbilt University Medical Center, 6140 Medical Research Building III, 465 21st Ave, South Nashville, TN 37232-8552, Tel: 615-936-8399; fax: 615-322-5517, <email>jingqiong.kang@vanderbilt.edu</email></corresp>
<fn id="FN1">
<label>9</label>
<p id="P1">lead contact</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>4</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>20</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>17</volume>
<issue>12</issue>
<fpage>3115</fpage>
<lpage>3124</lpage>
<!--elocation-id from pubmed: 10.1016/j.celrep.2016.11.067-->
<abstract id="Abs1">
<p id="P2">Reduced ocular pigmentation is common in Angelman syndrome (AS) and Prader-Willi syndrome (PWS) and long thought to be caused by <italic>OCA2</italic> deletion. <italic>GABRB3</italic> is located in the 15q11-13 region flanked by <italic>UBE3A, GABRA5, GABRG3</italic> and <italic>OCA2</italic>. Mutations in <italic>GABRB3</italic> have been frequently associated with epilepsy and autism, consistent with its role in neurodevelopment. We report here a robust phenotype in the mouse in which deletion of <italic>Gabrb3</italic> alone causes nearly complete loss of retinal pigmentation due to atrophied melanosomes, as evidenced by electron microscopy. Using exome and RNA sequencing, we confirmed that only the <italic>Gabrb3</italic> gene was disrupted while the <italic>Oca2</italic> gene was intact. However, mRNA abundance of <italic>Oca2</italic> and other genes adjacent to <italic>Gabrb3</italic> is substantially reduced in <italic>Gabrb3<sup>−/−</sup></italic> mice, suggesting complex transcriptional regulation in this region. These results suggest that impairment in <italic>GABRB3</italic> downregulates <italic>OCA2</italic> and indirectly causes ocular hypopigmentation and visual defects in AS and PWS.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical abstract</title>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms836970f5.jpg"></graphic>
</p>
</abstract>
<kwd-group>
<kwd>GABA<sub>A</sub> receptors</kwd>
<kwd>GABRB3</kwd>
<kwd>OCA2</kwd>
<kwd>deletion</kwd>
<kwd>epilepsy</kwd>
<kwd>autism</kwd>
<kwd>eye</kwd>
<kwd>hypopigmentation</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>